| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-16 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |